Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer

Cetuximab plus chemotherapy for advanced gastric cancer (GC) shows an active result in phase 2 trials. Unfortunately, Combination of cetuximab does not provide enough benefit to chemotherapy alone in phase 3 trials. Studies have demonstrated that berberine can suppress the activation of EGFR in tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Junxiong, Yang, Shuo, Cai, Xiqiang, Dong, Jiaqiang, Chen, Zhangqian, Wang, Rui, Zhang, Song, Cao, Haichao, Lu, Di, Jin, Tong, Nie, Yongzhan, Hao, Jianyu, Fan, Daiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342797/
https://www.ncbi.nlm.nih.gov/pubmed/27738318
http://dx.doi.org/10.18632/oncotarget.12589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342797/
https://www.ncbi.nlm.nih.gov/pubmed/27738318
http://dx.doi.org/10.18632/oncotarget.12589

Ejemplares similares